Lonza has launched a rapid custom media prototyping service aimed at helping life sciences customers accelerate the early-stage development of cell culture media formulations. The new service is designed for researchers and manufacturers involved in cell-based processes, providing a way to test and refine customized media more quickly.
According to Lonza, the offering brings together its expertise in cell culture technology, media development and manufacturing with a streamlined prototyping approach. Custom cell culture media is used across research, process development and biomanufacturing to provide the nutrients and conditions required for cell growth, productivity and product quality. Through the new rapid prototyping service, customers can evaluate media formulations more efficiently before progressing to larger-scale development or commercial production.
Tailored Media Prototypes for Life Sciences Applications
Lonza said the service is intended to give customers access to tailored media prototypes within shorter timelines than traditional development approaches. The company said the initiative is designed to reduce development complexity while helping organizations make informed decisions earlier in their programs. Using its scientific and technical capabilities, Lonza will develop prototypes according to customer-defined requirements.
The service will support a range of applications that depend on cell culture, including biopharmaceutical development and production. By providing early access to custom cell culture media formulations, the offering is intended to give customers greater flexibility as their requirements change. Companies can use the prototypes to assess cell and process performance under different conditions before deciding to proceed with larger manufacturing campaigns.
Supporting More Efficient Development Programs
The launch highlights Lonza’s focus on providing approaches that can help accelerate development timelines and reduce risk in biologics manufacturing. Rapid evaluation of custom cell culture media options can allow customers to examine potential formulations earlier in their development programs and support more efficient project progression.
The company has not disclosed pricing, availability timelines or specific customer programs connected with the new service. Lonza said the offering forms part of its broader work in cell culture media and services for the life sciences industry.
